Board of Directors Bios



Augustine Chow – Director

Dr. Augustine Chow, PhD, is the Chairman of Harmony Asset Management Limited in Hong Kong. He is also Director of Medifocus Inc. (TSX Venture: MFS). From 1996-2015, Dr. Chow was the Chief Executive Office of Harmony Asset Limited, a Hong Kong listed investment company, and from 2008-2016 Executive Director of Kaisun Energy Group Limited. From 1990 to 1998, Dr. Chow was the Chief Executive Officer of Allied Group of Companies based in Hong Kong which include a number of publicly listed companies spanning across various different industries. Prior to this, Dr. Chow held a senior position with Brunswick Corporation and Outboard Marine Corporation and was responsible for all business activities in South East Asia and China. Dr. Chow has extensive experience in managing public listed companies that are involved in manufacturing, marketing and financial services and specializes in mergers and acquisitions. Dr. Chow’s qualifications include a number of Bachelors, Masters and Doctoral degrees. Among them include a MSc from London Business School, a PhD from the University of South Australia, an Engineering Doctorate and PhD in Biology from City University of Hong Kong.

Dr. Raymond C.F. Tong – Director

Dr Raymond C. F. Tong, M.D., 56, is the Chief Executive Officer of Harmony Medical Inc, an Asian investment group active in the introduction and distribution of medical and healthcare products and services in China and the Asia. Dr. Tong obtained his medical degree from the University of Toronto. He is also an independent Director of Shanghai CP Guojian Pharmaceutical, the largest bio-pharmaceutical manufacturer in China, and is also Chairman of Shanghai Kedu Healthcare Group, one of the largest medical equipment distributor and third-party service provider in China, representing products from GE, Philips, Siemens and Kodak and other multi-nationals. Dr Tong’s earlier career included senior management positions in China with Pfizer and Ball Corporation. He was also responsible for the Healthcare Investment Division of CITIC Pacific in Hong Kong.